Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Vaccines|August 28, 2025
Economic Impacts of Initiating Vaccination at 3 Months vs. 6 Months in an Influenza Pandemic in the United StatesVan Hung Nguyen, Pascal Crepey, B Adam Williams, et al.
Drug Discovery Today|August 3, 2024
Deciphering immune responses: a comparative analysis of influenza vaccination platformsCharles H Jones, Teresa Hauguel, Marie Beitelshees, et al.
NPJ Vaccines|March 29, 2025
Modeling the impact of early vaccination in an influenza pandemic in the United StatesVan Hung Nguyen, Pascal Crépey, B Adam Williams, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 13, 2014
Hybrid biosynthetic gene therapy vector development and dual engineering capacityCharles H Jones, Anitha Ravikrishnan, Mingfu Chen, et al.
Molecular Pharmaceutics|January 28, 2015
PEGylated cationic polylactides for hybrid biosynthetic gene deliveryCharles H Jones, Chih-Kuang Chen, Mingfu Chen, et al.
Biomacromolecules|April 8, 2015
Structure-Function Assessment of Mannosylated Poly(β-amino esters) upon Targeted Antigen Presenting Cell Gene DeliveryCharles H Jones, Mingfu Chen, Akhila Gollakota, et al.
NPJ Genomic Medicine|January 9, 2024
Breaking the mold with RNA-a "RNAissance" of life scienceCharles H Jones, John R Androsavich, Nina So, et al.
Science Advances|October 24, 2017
Comprehensive vaccine design for commensal disease progressionCharles H Jones, Guojian Zhang, Roozbeh Nayerhoda, et al.
Biomaterials|September 17, 2013
Poly(ethylene glycol)-block-cationic polylactide nanocomplexes of differing charge density for gene deliveryChih-Kuang Chen, Charles H Jones, Panagiotis Mistriotis, et al.
Vaccine: X|August 7, 2019
Antigen delivery format variation and formulation stability through use of a hybrid vectorMarie Beitelshees, Andrew Hill, Yi Li, et al.
Pageof 5